Genelux Corporation

NASDAQ:GNLX

Biotechnology

Healthcare
$2.24 +2.63%

+$0.08 today

Market cap
$107.66M
Beta
0.55
P/E (TTM)
-3.0
EPS (TTM)
-$0.98
52W Low $2.29High $8.54

Volume 0.80M

Average 0.19M

Price history

Genelux Corporation SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-55.73%

Period high

$5.59

Period low

$1.82

Latest

$2.24

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 5, 2026Nov 5, 2026
4Nov 5, 2026Nov 5, 2026
4Nov 5, 2026Nov 5, 2026
SC 13G/ANov 4, 2026Nov 4, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
10-QAug 13, 2026Aug 13, 2026
4Aug 4, 2026Aug 4, 2026
4Aug 4, 2026Aug 4, 2026
4Aug 4, 2026Aug 4, 2026
4Jul 2, 2026Jul 2, 2026
8-KJun 22, 2026Jun 22, 2026
4Jun 18, 2026Jun 18, 2026
4Jun 18, 2026Jun 18, 2026

Competitors

Who does Genelux Corporation compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about GNLX's filings, answered from its disclosures.

What is the latest GNLX filing?

The latest filing shown is 4 dated Nov 5, 2026.

How many recent filings does GNLX have?

Intrinsic Alpha currently shows 20 recent filings for GNLX.